Respiratory Market Size & Demand

Chronic respiratory disease is one of the most durable sources of clinical demand in medicine. COPD, asthma, obstructive sleep apnoea, pulmonary fibrosis and post-viral lung disease all generate repeat, longitudinal encounters rather than one-off visits, which is exactly the demand profile a lender wants to see behind a specialty practice. The plan you build should anchor to that structural demand and then translate it into a realistic patient panel and collections forecast.

The wider respiratory care market was valued at roughly USD 31.46 billion in 2026 and is projected to reach USD 62.10 billion by 2033, a compound annual growth rate of 10.2% (Coherent Market Insights, 2026). On the device side, the pulmonology devices market sat at about USD 1,703.2 million in 2025 and is forecast to reach USD 4,417.7 million by 2035 at close to a 10% CAGR (Future Market Insights, 2025). Those figures describe the equipment and services ecosystem around your practice, not your own revenue, but they tell an investor the category is expanding rather than contracting.

Demographics reinforce the demand story. The population is ageing, smoking-related disease burden persists in older cohorts, and post-viral respiratory follow-up has become a permanent line of care since 2020. For an owner, the relevant number is not the global market at all — it is how many referring primary-care physicians, urgent-care centres and hospitalists sit within a 20-minute drive of your clinic, and how many pulmonary referrals they generate each month. A credible plan names those referral sources and estimates the panel they can realistically feed.

Professional bodies such as the American College of Chest Physicians (CHEST) and the American Thoracic Society (ATS) publish practice and workforce data that lenders recognise, and citing them signals you have done more than sketch a hopeful curve.

There is also a workforce dynamic that helps a new practice. Pulmonology, together with critical care, faces a projected shortfall of specialists relative to demand as the population ages and chronic respiratory disease prevalence rises. Fewer competing specialists in a given geography means a new practice can build a referral base faster, provided it delivers fast access and reliable reporting. The plan should note the local supply of pulmonologists per capita where the data is available, because a thin supply is a genuine tailwind that an underwriter will weigh in the practice's favour.

Telemedicine has also become a permanent part of the service model. Remote follow-up for stable chronic patients, remote review of home sleep tests, and virtual triage of new referrals all extend a practice's reach without adding exam-room cost. Reimbursement policy for telehealth has stabilised enough that a plan can model a modest share of encounters as virtual, which improves provider utilisation and widens the effective catchment beyond a single clinic's drive time. The plan should state the assumed virtual share and its effect on capacity rather than treating telehealth as an afterthought.

SBA & Practice Financing Data

Physician practices are classified under NAICS 621111, Offices of Physicians (except Mental Health Specialists). That code matters because it sets your SBA size standard: a practice qualifies as a small business if average annual receipts stay under $16 million (NAICS 621111 reference). Almost every solo-to-mid-size pulmonology practice sits comfortably inside that ceiling, so SBA-backed financing is on the table.

The workhorse product is the SBA 7(a) loan, which runs from about $50,000 up to $5 million and can fund fit-out, equipment, working capital, practice acquisition, or refinancing of higher-interest startup debt (SBA 7(a).loans). Healthcare is one of the SBA's most-served sectors because practices have predictable receivables once credentialing completes, which lowers perceived lender risk.

• Product: SBA 7(a) — the default for a new or acquired pulmonology practice; 10-year working-capital terms, up to 25 years when real estate is involved.
• SBA 504: better fit if you are buying the clinic building rather than leasing; splits the loan across a bank and a Certified Development Company.
• Equipment financing / leasing: spreads the cost of PFT systems and imaging over their useful life instead of consuming launch capital.
• Bank practice-financing lines: lenders such as US Bank market dedicated physician-practice loan programmes that assume the credentialing lag.

The single document every one of these routes demands is a business plan with an honest financial model. Lenders underwriting NAICS 621111 borrowers are not swayed by market-size slides; they read the debt-service coverage ratio, the ramp assumptions, and whether you budgeted for the credentialing gap. That is why the plan structure below leads with net collections, not gross charges.

UK founders have a parallel path. Start Up Loans (a government-backed scheme) lend up to £25,000 per director at 6% fixed, which rarely covers a full clinic but can seed the first fit-out phase, with commercial healthcare lenders and asset finance covering the rest.

What It Costs to Open a Pulmonology Practice

Budget $150,000 to $500,000 (about £120,000 to £400,000) to open, with the spread driven by whether you lease a shell and fit it out or take assigned space, how much diagnostic capability you install on day one, and how deep a working-capital reserve you hold (Fullscript; DoctorsManagement, 2026). The single most under-modelled line is not equipment or rent — it is the cash you burn before payers start paying.

Cost Breakdown

• First-year staff salaries (clinical and admin): $200K–$500K (£160K–£400K) — a nurse or respiratory therapist, front desk, and a dedicated biller.
• Clinical fit-out and renovation: $50K–$250K (£40K–£200K) depending on shell condition and exam-room count.
• Diagnostic equipment: $20K–$100K (£16K–£80K) for spirometry, full PFT, diffusion capacity, and optional sleep testing.
• Malpractice / professional indemnity insurance: $7.5K–$50K per year (£8K–£40K), varying by state and procedure mix.
• EHR, billing software and IT: $10K–$40K (£8K–£32K) for setup plus per-provider licensing.
• Branding, website and launch marketing: $2.5K–$10K (£2K–£8K) for a mobile-first, referral-friendly site.
• Working-capital reserve: 3–6 months of payroll and rent to bridge the credentialing window before collections begin.

The lease-versus-buy decision on the clinic space is the biggest single swing in the budget. Taking assigned or shared space inside an existing medical building keeps fit-out low and can put a lean practice near the $150,000 floor, at the cost of less control over layout and branding. Building out a dedicated shell gives a purpose-designed PFT lab and sleep suite but pushes the number toward the $500,000 ceiling and lengthens the pre-opening timeline. The plan should state which path the founder is taking and why, because a lender reads the two scenarios very differently: one is a lower-risk, faster-to-revenue launch, the other a higher-capital bet on a long-term flagship location.

Funding Routes

In the US, SBA 7(a) loans (up to $5M under NAICS 621111), equipment leasing, and bank physician-practice lines cover most launches. In the UK, Start Up Loans (up to £25,000 at 6% fixed), asset finance, and commercial healthcare lenders apply. Many founders combine personal savings with an SBA loan and lease the highest-cost diagnostic hardware to protect launch cash. Whichever route you choose, the application stands or falls on the financial model, so build it first and let the funding ask fall out of the numbers.

Diagnostic Equipment Checklist

Diagnostic capability is what separates a pulmonology practice from a general internal-medicine office, and it is where ancillary revenue comes from. Spirometry and pulmonary function testing are the backbone; sleep testing and bronchoscopy are optional layers that raise both capability and capital cost. Named vendors below are the ones pulmonologists actually shortlist.

Two decisions drive this budget. First, in-house versus outsourced sleep studies: an on-site sleep line lifts revenue but adds capital and accreditation work. Second, whether you offer bronchoscopy at launch or refer it out until volume justifies the tower. A lender-ready plan states these choices explicitly and shows the payback period for each piece of hardware, using vendor quotes from suppliers such as ndd Medical Technologies, Vitalograph and MGC Diagnostics rather than round-number guesses.

Revenue, Billing & Unit Economics

Pulmonology revenue is a blend, and the plan should model each stream separately: evaluation-and-management office visits, pulmonary function and spirometry testing, sleep studies, bronchoscopy and procedures, and chronic-disease management for COPD and asthma panels. The mix matters because ancillary testing carries different margins than office visits, and because each code has its own denial behaviour.

The number that undoes weak plans is the gap between charges and collections. Pulmonary medicine runs an average claim-denial rate near 18%, roughly double the 5% to 10% seen across other specialties (Transcure). The most common cause is spirometry being bundled into the office visit: when CPT 94010 is performed the same day as an E/M service, payers bundle the two unless documentation supports a separately identifiable service with the correct modifier. Model revenue on net collections, staff a competent biller, and treat clean-claim rate as a first-class KPI.

Worked Example

Consider a two-provider practice seeing 34 encounters per day across 220 working days (about 7,480 encounters annually). At a blended $185 net collection per encounter after the denial and adjustment haircut, that is roughly $1.38M from encounters, lifted toward $2.75M gross collections once PFT, sleep and procedure ancillaries are layered on. With overhead near 78% of collections in the ramp years — staffing, rent, insurance, billing — the practice nets around $600K before founder distributions. Those distributions are what pull owner pay toward the private-practice benchmarks below.

On compensation, SalaryDr's 2026 data puts median pulmonology total comp near $460,000, with the 25th percentile at $360,000 and the 75th at $530,000 (SalaryDr, 2026). Ownership structure changes the picture sharply: practice partners average about $310,000 and solo owners about $274,000, while employed pulmonologists average roughly $237,000. Owners earn more, but they absorb overhead, the credentialing cash-flow lag, and business risk that an employed role does not carry. A realistic plan shows the owner taking a modest draw in year one and scaling distributions as collections mature.

Net margin after physician compensation typically lands in the 8% to 22% band once volume and ancillaries stabilise. Practices that push toward the top of that range do it by protecting clean-claim rate, keeping PFT and sleep capacity full, and holding administrative overhead down — not by raising charges.

Two structural revenue drivers deserve their own lines in the model. The first is the ancillary-to-office-visit ratio: a practice that runs PFT, diffusion capacity, and sleep testing at healthy volume earns materially more per patient than one that bills office visits alone, because those tests carry technical-component reimbursement the practice keeps. The second is chronic-disease management: COPD and asthma patients enrolled in structured management generate predictable recurring encounters, and where chronic-care-management billing applies, an additional monthly line. Modelling these two drivers separately, rather than folding them into a blended per-visit average, is what lets a plan explain why collections climb from year one to year three rather than simply asserting growth.

The cost side has its own non-obvious lines. Billing and collections, whether staffed in-house or outsourced, typically runs 4% to 8% of collections in a specialty with this denial profile, and skimping on it costs more than it saves. Diagnostic-equipment service contracts and calibration are recurring, not one-time. And malpractice premiums scale with the procedure mix: a practice offering bronchoscopy carries a higher premium than one that refers procedures out. A plan that surfaces these lines explicitly reads as the work of an operator, not an optimist, and that credibility is worth real basis points at the underwriting table.

Patient Panel & Referral Strategy

Pulmonology is a referral-driven specialty. Unlike a retail clinic that markets to walk-in patients, a pulmonology practice fills its schedule through relationships with the physicians and facilities that generate lung-disease referrals. The plan should name those sources and estimate the monthly referral volume each can realistically send, rather than assuming a generic catchment. That level of specificity is what turns a hopeful forecast into one an underwriter will trust.

• Primary-care physicians and family medicine groups: the largest single referral source, sending COPD, asthma, chronic cough, and abnormal-imaging cases for specialist workup.
• Hospitalists and discharge planners: post-admission follow-up for pneumonia, respiratory failure, and exacerbations, often on a fixed timeline that fills recurring slots.
• Urgent-care and emergency departments: episodic referrals for patients who need specialist follow-up after an acute respiratory event.
• Sleep-symptom self-referrals and screening programmes: a growing channel where the practice runs a sleep clinic and accepts direct or employer-screened referrals.

The economics of the panel matter as much as its size. A payer mix weighted toward Medicare reflects the older, chronic-disease demographic that dominates pulmonology, and Medicare reimbursement sets a floor that the plan should model explicitly rather than blending into an average. Commercial payers reimburse ancillary testing more generously, so a practice that can attract a balanced mix of Medicare and commercial patients protects both volume and margin. The plan should show the assumed split and the collection rate on each.

Retention compounds the referral engine. A COPD or interstitial-lung-disease patient is not a one-visit event; they return quarterly for years, generating spirometry, diffusion-capacity testing, and management encounters. Modelling the lifetime value of a chronic-disease patient, rather than a single visit, gives a far more accurate picture of practice revenue and shows a lender that demand is durable rather than episodic. The strongest plans quantify how many active chronic patients the practice needs to carry to hit its collections target, then work backward to the referral volume required to build that panel.

Competitive Positioning

The competition for a pulmonology practice is not only other independent pulmonologists. It includes hospital-owned outpatient pulmonary departments, multispecialty groups with a pulmonology division, and, increasingly, the pull of hospital employment that keeps referring physicians inside a closed system. A credible plan maps each of these layers and states where the independent practice wins.

• Hospital outpatient pulmonary: deep resources and integrated imaging, but longer wait times and less personal continuity. An independent practice competes on access speed and physician continuity.
• Multispecialty groups: convenient one-roof care and internal referrals, but pulmonology can be a low priority within the group. A focused practice competes on specialist depth and faster PFT turnaround.
• Employed-model gravity: as more referrers join hospital systems, independent practices must actively cultivate the referrers who remain independent or value choice.

A useful discipline is to build a short competitor table for the specific catchment: list the nearest pulmonology options, their approximate new-patient wait time, whether they offer in-house PFT and sleep testing, and their ownership model. That table almost always reveals a gap the new practice can occupy, whether it is faster access, a service the incumbents refer out, or a referrer segment the hospital systems neglect. Naming that gap concretely is far more persuasive than a generic claim to be patient-centred.

Differentiation in pulmonology rarely comes from price, because reimbursement is largely set by payers. It comes from access and experience: how quickly a referred patient is seen, how fast PFT and sleep results reach the referring physician, and how reliably the practice communicates back into the referral loop. A practice that guarantees a new-patient appointment within a week, and same-week PFT interpretation back to the referrer, has a defensible position that hospital outpatient departments struggle to match. The plan should make that service promise concrete and tie it to the operational design below.

Operations & Clinic Workflow

Operationally, a pulmonology practice is a scheduling and testing business as much as a clinical one. Margin is won or lost in how tightly the practice runs its PFT lab, its sleep line, and its billing function. The plan should describe the day-one workflow and the KPIs the owner will watch weekly.

• PFT lab utilisation: testing capacity is a fixed cost once installed, so keeping the lab full is the fastest lever on ancillary revenue. Track slots booked versus available.
• Clean-claim rate: given the ~18% pulmonary denial rate, the percentage of claims that pass on first submission is a direct margin driver. Aim to push it well above sector norms.
• Referral turnaround: the time from referral received to patient seen, and from test performed to result returned. Both protect the referral relationships that feed the practice.
• Days in accounts receivable: how long collections take, which drives the working-capital reserve the practice must hold.

Year-One Operating Priorities

• Complete payer credentialing before opening and hold a funded reserve to bridge the 90 to 150 day gap.
• Stand up a dedicated billing function, in-house or outsourced, that understands spirometry-bundling rules and modifier use.
• Document PFT and sleep-study workflows so testing quality and coding are repeatable from day one.
• Build the referral-communication loop so every referring physician receives a timely, legible report.

Staffing follows the workflow. A minimal launch team is the physician, a nurse or respiratory therapist to run testing, a front-desk coordinator, and a biller. As volume grows, a second provider and a mid-level clinician extend capacity without proportionally raising fixed cost, which is how the practice moves toward the upper end of the 8% to 22% net-margin band.

Licensing Across Three Jurisdictions

Credentialing and licensing are not paperwork footnotes for a pulmonology practice; they set your earliest billable date, which is the hinge of your first-year cash flow. Below are the specific bodies and typical timelines in three markets.

United States

• State medical license from the state medical board, held before you see patients ($700–$2,500; 60–120 days).
• ABIM pulmonary board certification from the American Board of Internal Medicine — expected by most payers and referrers.
• DEA registration to prescribe controlled substances ($888 for three years; 4–6 weeks).
• Payer credentialing with Medicare and commercial insurers — the 90–150 day step that gates most of your revenue.
• HIPAA compliance and OSHA bloodborne pathogen programmes; malpractice cover, commonly $1M/$3M minimum.

United Kingdom

• CQC registration as an independent doctor or clinic through the Care Quality Commission — about £1,743 per site annually, 10–14 weeks to grant.
• GMC full registration and entry on the specialist register (General Medical Council), plus annual retention around £433.
• ICO data-protection registration — a valid ICO certificate is required before the CQC will grant registration.
• Professional indemnity (typically £10M+ cover for medical work), enhanced DBS check, and employers' liability insurance.

International (Australia & UAE)

• Australia: AHPRA specialist registration, a state or territory health-facility licence, a Medicare provider number, and GST registration once turnover exceeds AUD75,000.
• UAE: a physician licence from the DHA or DOH via the Sheryan platform, plus a mainland or free-zone clinic facility licence; visa sponsorship for staff.

Across all three markets, the recurring lesson is timing: build the licensing and credentialing calendar into the plan and fund the gap, rather than assuming revenue starts the day the doors open.

Costly Mistakes to Avoid

These are the failures that show up repeatedly when pulmonology plans reach a lender or an accountant, and each is avoidable with better modelling.

• Modelling on gross charges, not net collections. Ignoring the ~18% pulmonary denial rate overstates revenue by a fifth and destroys the plan's credibility the moment a lender checks it.
• Launching before credentialing completes. Opening the doors with 90–150 days of unbillable overhead and no reserve is the most common way new practices run out of cash in month four.
• Under-budgeting diagnostic equipment. PFT and sleep testing are the ancillary revenue that lifts a pulmonology practice above a general office; skimping here caps the ceiling.
• Borrowing employed-physician productivity for an owner P&L. Solo owners carry overhead an employee never sees, so copying an employed-comp benchmark into an ownership model inflates take-home.
• No dedicated billing function. With spirometry-bundling denials this frequent, treating billing as a part-time front-desk task quietly leaks margin every week.

Sample Business Plan Preview

Preview the structure and financial outputs a buyer receives. These visual mockups are generated from the same assumptions used throughout this page.

What's Inside the Template

Every Avvale business plan template ships pre-structured for your industry. For pulmonology, that means the financial framework already reflects net collections, the credentialing gap, and ancillary testing lines:

• Executive Summary — your practice at a glance, written to convince a lender in 60 seconds.
• Company Overview — legal structure, ownership, location, and the referral catchment you serve.
• Industry Analysis — respiratory demand drivers, market growth, and the regulatory picture.
• Patient & Referral Analysis — payer mix, referring-physician map, and target panel size.
• Competitor Analysis — nearby pulmonology and hospital outpatient options, and where you differentiate.
• Marketing Plan — referral relationships, a mobile-first site, and reputation channels.
• Operations Plan — clinic workflow, PFT and sleep scheduling, and the billing function.
• Management Team — physician credentials, planned hires, and advisory support.

The optional Financial Forecast add-on (included in the $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and startup capital requirements — already wired for the credentialing lag and denial haircut that define pulmonology economics. For the underlying research inputs you can also add our market research and content package, or start from the free business plan template.

Frequently Asked Questions

Useful Links & Resources

Related Avvale resources and reference bodies for founders planning a pulmonology practice.

• Bespoke business plan service
• Work with a business plan writer
• Facebook
• LinkedIn